NIH Grants $26M to Washington University’s Large Scale Alzheimer’s Trial

NIH Grants $26M to Washington University’s Large Scale Alzheimer’s Trial

NIHThe National Institutes of Health (NIH) has granted $5.5 million in funding to expand the first large-scale study that aims to identify drugs able to stop or slow the progression of Alzheimer's disease, which is being conducted by the Washington University School of Medicine in St. Louis. The National Institute on Aging from the NIH will support the trial, dubbed the Dominan

Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *